A must-attend webinar for any manufacturer preparing for IPAY 2027 and beyond!
In this webinar, a joint team of advisors from Verpora and Manatt Health, who span the world of negotiation strategy, legal and regulatory counsel, government health technology assessment, and the science of human performance factors, will share their:
Unique approach to helping brands navigate IPAY 2026 negotiations
Vital learnings from the process
Critical recommendations for future negotiations
Essential do’s and don’ts
Benefits of Attending
Gain the inside track on how to structure the brand for success
Save time and organizational resources during your preparations
Optimize future negotiations
Ask questions to those who lived through the IPAY 2026 process
Join Us, Live: September 18, 2024
This webinar is now available to watch On-Demand
Watch now via our On-Demand library
REQUEST ACCESSBackground
In 2023, ten brand’s manufacturers were the first to be compelled to negotiate Maximum Fair Prices (MFP) for Medicare Part D drugs with the Centers for Medicare & Medicaid Services. Results of this process reveal a significant variance across each of these new MFPs and the existing, estimated, average net prices for each of the products:
Reference 1 & 2. Source: https://www.manatt.com/insights/newsletters/health-highlights/the-inflation-reduction-act-infographic-overview-o
While there may be many reasons for the differences, the joint team of advisors from Verpora and Manatt Health will outline their key strategies to minimize the delta based on their experience working together with manufacturers during this process.
Core themes to be covered:
Importance of early preparation
Building, training and empowering the right cross-functional team
Potential submission mistakes and omissions
Payer psychology and the science of human factors in government negotiations
Setting and executing the negotiation strategy
Format & Duration
45-minute fireside chat with a panel of professionals involved in IPAY 2026, followed by 15-minutes audience Q&A.
Who Should Attend?
Personnel from pharmaceutical manufacturers in the following functions will benefit from attending the webinar:
| Brand | Contract Operations | Contract Strategy |
| Corporate Communications | Government Affairs | Finance |
| Leadership | Legal | Managed Markets |
| Market Access | Pricing Operations | Real-world Evidence |
| Government Pricing | Marketing | Key Accounts |
Watch now via our On-Demand library
REQUEST ACCESSSpeakers
Erin Estey Hertzog
Partner, Manatt Health
Over 15 years of experience as a healthcare regulatory attorney, including extensive experience advising manufacturers on their engagements with CMS.
LinkedIn
Ross Margulies
Partner, Manatt Health
Over 15 years of experience as a healthcare regulatory attorney, including extensive experience advising manufacturers on their engagements with CMS.
LinkedIn
Chris Webber
Head of Negotiation, Verpora
20+ years advising pharmaceutical manufacturer negotiations with governments, health insurers, and PBMs both in the U.S. and globally.
LinkedIn
Omar Ali
Head of Payers, Verpora
Former Health Technology Assessment advisor to NICE with 25+ years experience supporting manufacturers in government and commercial negotiations both in the U.S. and globally.
LinkedIn
Nick Merryfield
CEO, Verpora
& Webinar Chair
Nick is a pioneer in the field of applying the aviation-based science of Human Factors to pharmaceutical negotiations and organizational efficiency.
LinkedIn
Watch now via our On-Demand library
REQUEST ACCESS
About Verpora
Verpora is a highly specialized consultancy in the field of innovative contracting and value-based pricing for the life sciences industry.
In a novel, first-of-its-kind approach, Verpora has pioneered the integration of human performance factors with payer behavior, data science and commercial negotiation strategy to deliver outcomes that are outstanding.
When healthcare innovations struggle to demonstrate their true value to stakeholders, Verpora’s team of experts leverage the relationship between people, data, and the systems in which they interact to optimize patient access and price for healthcare technologies.
About Manatt
Manatt is a multidisciplinary, integrated national professional services firm known for quality and an extraordinary commitment to clients. We are keenly focused on specific industry sectors, providing legal and consulting capabilities at the very highest levels to achieve our clients’ business objectives.
Our groundbreaking approach—bringing together legal services, advocacy and business strategy—differentiates us from our competitors and positions us to provide a unique and compelling value proposition. We strive to be essential to our clients.
References
Source for Estimated Non-FAMP, Estimated Part D Net Price, and Estimated Ceiling Price is “Prince Benchmarks of Drugs Selected for Medicare Price Negotiation and Their Therapeutic Alternatives,” J. Managed Care Spec. Pharm. (JMCP), 2024; 30(8):762-772
Infographic Source: https://www.manatt.com/insights/newsletters/health-highlights/the-inflation-reduction-act-infographic-overview-o